Return to content in this issue
Diagnostic Capacity of Commercial Extracts vs Prick-by-Prick in the Study of Sensitization to Peanut: Which Technique Should We Use?
D’Amelio CM1*, García-Moral A2, Bartra J2,3*, Azofra J4*, García Blanca E5*, Quiñones MD6, Goikoetxea MJ1*, Martínez- Aranguren R1, Gastaminza G1*
1Clínica Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain
2Hospital Clínic, Barcelona, Spain
3Hospital Clínic, Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
4Hospital Universitario Central de Oviedo, Oviedo, Spain
5Complejo Hospitalario de Navarra, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
6Hospital Monte Naranco, Oviedo, Spain
*Member of the Spanish Research Network on Allergy (ARADyAL: Red Nacional de Alergia -Asma, Reacciones Adversas y Alérgicas-) RD 16/0006/0031, RD16/0006/0007, of the Carlos III Health Institute, Madrid, Spain
J Investig Allergol Clin Immunol 2020; Vol 30(5)
: 373-375
doi: 10.18176/jiaci.0555
Key words: Skin prick test, Prick-by-prick, Allergy, Peanut, Commercial extract
Title | Type | Size | |
---|---|---|---|
doi10.18176_jiaci.0555_material-suppl_1.pdf | 211.86 Kb |